Cause and effect relationship between application of deuterium-depleted water and improvement of chronic lymphocytic leukemia
The anticancer effect of deuterium depletion has been proved in various types of cancer in combination with conventional therapies. Here we report a case study of a patient diagnosed in 2006 with chronic lymphocytic leukemia (CLL). His stage at diagnosis did not require the immediate conventional therapy and so he started consuming deuterium-depleted water (DDW). Significant changes occurred already during the first three months; WBC count dropped from 16x10 3 cells/µL to 7.7x10 3 cells/µL, to the normal range and the cervical lymph nodes regressed. He continued drinking DDW uninterruptedly in the first three years (1,231 days) and periodically in the subsequent 11 years. PLT count significantly increased from 108x10 3 /µL to 232x10 3 /µL after two years' DDW-consumption. CD5+/CD19+ percentage showed significant decrease from 69% to 4% and the rate of chromosome trisomy 12 in interphase blood cells was reduced from 40% to 7% in the first three years. The study confirms that deuterium depletion as a single treatment is effective and delays the use of conventional chemotherapy.